| Primary |
| Product Used For Unknown Indication |
27.9% |
| Neuralgia |
13.8% |
| Pain |
13.3% |
| Neuropathy Peripheral |
5.9% |
| Hypertension |
5.6% |
| Drug Use For Unknown Indication |
4.2% |
| Epilepsy |
3.9% |
| Diabetic Neuropathy |
3.6% |
| Fibromyalgia |
3.0% |
| Back Pain |
3.0% |
| Depression |
2.4% |
| Anxiety |
2.0% |
| Pain In Extremity |
1.9% |
| Convulsion |
1.7% |
| Diabetes Mellitus |
1.6% |
| Nerve Injury |
1.4% |
| Post Herpetic Neuralgia |
1.4% |
| General Anaesthesia |
1.3% |
| Migraine |
1.2% |
| Trigeminal Neuralgia |
1.1% |
|
| Drug Ineffective |
19.7% |
| Somnolence |
7.8% |
| Tremor |
7.2% |
| Completed Suicide |
6.2% |
| Off Label Use |
6.0% |
| Pain |
5.7% |
| Weight Increased |
4.9% |
| Suicidal Ideation |
4.2% |
| Drug Hypersensitivity |
4.0% |
| Vision Blurred |
3.9% |
| Vomiting |
3.8% |
| Respiratory Arrest |
3.7% |
| Withdrawal Syndrome |
3.4% |
| Drug Abuse |
3.4% |
| Pain In Extremity |
3.4% |
| Death |
2.8% |
| Rash |
2.6% |
| Nausea |
2.5% |
| Paraesthesia |
2.5% |
| Dizziness |
2.4% |
|
| Secondary |
| Product Used For Unknown Indication |
27.6% |
| Drug Use For Unknown Indication |
13.5% |
| Pain |
10.9% |
| Neuralgia |
7.7% |
| Neuropathy Peripheral |
5.8% |
| Hypertension |
4.7% |
| Fibromyalgia |
4.4% |
| Epilepsy |
3.3% |
| Depression |
3.0% |
| Back Pain |
2.6% |
| Anxiety |
2.5% |
| Convulsion |
2.1% |
| Pain In Extremity |
2.0% |
| Diabetic Neuropathy |
2.0% |
| Nerve Injury |
1.6% |
| Diabetes Mellitus |
1.5% |
| Muscle Spasms |
1.4% |
| Migraine |
1.3% |
| Blood Cholesterol Increased |
1.1% |
| Headache |
1.1% |
|
| Completed Suicide |
16.7% |
| Weight Increased |
11.1% |
| Drug Ineffective |
9.3% |
| Toxicity To Various Agents |
7.9% |
| Somnolence |
5.9% |
| Respiratory Arrest |
5.2% |
| Pain |
5.0% |
| Off Label Use |
4.4% |
| Death |
4.2% |
| Weight Decreased |
4.1% |
| Vomiting |
3.6% |
| Vision Blurred |
3.2% |
| Poisoning |
3.0% |
| Pain In Extremity |
2.7% |
| Tremor |
2.7% |
| Suicidal Ideation |
2.5% |
| Withdrawal Syndrome |
2.5% |
| Suicide Attempt |
2.3% |
| Visual Impairment |
1.9% |
| Cardio-respiratory Arrest |
1.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
33.7% |
| Drug Use For Unknown Indication |
14.6% |
| Pain |
8.5% |
| Hypertension |
5.6% |
| Depression |
4.3% |
| Multiple Sclerosis |
4.3% |
| Rheumatoid Arthritis |
3.6% |
| Diabetes Mellitus |
2.8% |
| Prophylaxis |
2.7% |
| Multiple Myeloma |
2.6% |
| Gastrooesophageal Reflux Disease |
2.3% |
| Anxiety |
2.2% |
| Neuralgia |
2.0% |
| Neuropathy Peripheral |
1.8% |
| Back Pain |
1.7% |
| Insomnia |
1.6% |
| Blood Cholesterol Increased |
1.6% |
| Osteoporosis |
1.5% |
| Hiv Infection |
1.4% |
| Nausea |
1.4% |
|
| Vomiting |
14.7% |
| Weight Decreased |
8.5% |
| Weight Increased |
6.3% |
| Death |
5.9% |
| Pain |
5.7% |
| Urinary Tract Infection |
5.3% |
| Drug Ineffective |
5.2% |
| Nausea |
5.1% |
| Pneumonia |
4.7% |
| Tremor |
4.2% |
| Wrong Technique In Drug Usage Process |
4.2% |
| Pain In Extremity |
4.0% |
| White Blood Cell Count Decreased |
3.9% |
| Vision Blurred |
3.7% |
| Somnolence |
3.3% |
| Pyrexia |
3.2% |
| Rash |
3.2% |
| Type 2 Diabetes Mellitus |
3.1% |
| Syncope |
2.9% |
| Myocardial Infarction |
2.9% |
|
| Interacting |
| General Anaesthesia |
21.4% |
| Drug Use For Unknown Indication |
13.3% |
| Osteotomy |
11.8% |
| Pain |
9.9% |
| Product Used For Unknown Indication |
8.6% |
| Musculoskeletal Pain |
8.4% |
| Neuralgia |
6.8% |
| Anaesthesia |
3.0% |
| Varicose Vein Operation |
2.8% |
| Maintenance Of Anaesthesia |
2.5% |
| Fibromyalgia |
1.8% |
| Pain In Extremity |
1.7% |
| Induction Of Anaesthesia |
1.5% |
| Neuropathy Peripheral |
1.3% |
| Asthma |
1.1% |
| Analgesia |
0.9% |
| Convulsion |
0.9% |
| Sleep Disorder |
0.9% |
| Anxiety |
0.8% |
| Multiple Sclerosis |
0.8% |
|
| Drug Interaction |
15.0% |
| Sinus Tachycardia |
15.0% |
| Myotonia |
14.3% |
| Somnolence |
12.1% |
| Rash |
10.7% |
| Tremor |
7.1% |
| Hypoventilation |
2.9% |
| Confusional State |
2.1% |
| Dyskinesia |
2.1% |
| Prescribed Overdose |
2.1% |
| Rhabdomyolysis |
2.1% |
| Tooth Disorder |
2.1% |
| Withdrawal Syndrome |
2.1% |
| Fatigue |
1.4% |
| General Physical Health Deterioration |
1.4% |
| Motor Dysfunction |
1.4% |
| Nausea |
1.4% |
| No Adverse Event |
1.4% |
| Oedema Mouth |
1.4% |
| Pain |
1.4% |
|
